1
Amlexanox for Type 2 Diabetes and Obesity
Condition(s):Diabetes Mellitus Type 2; Non Alcoholic Fatty Liver Disease; ObesityLast Updated:February 14, 2023Suspended
Hide Studies Not Open or Pending
Condition(s):Diabetes Mellitus Type 2; Non Alcoholic Fatty Liver Disease; ObesityLast Updated:February 14, 2023Suspended
Condition(s):Diabetes Mellitus Type 2; Non-alcoholic Fatty Liver Disease; ObesityLast Updated:November 7, 2018Completed
Condition(s):Oral MucositisLast Updated:March 18, 2010Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.